Skip to main content
13 August 2026
06 October 2025

Saya Bio, Maxigen Biotech Announce Strategic Osteoarthritis Collaboration

 Saya Biologics (Saya Bio), a Mexican biopharmaceutical company committed to expanding patient access to innovative, high-quality, and affordable biological treatments, and Maxigen Biotech Inc., an international company specializing in the development and manufacture of hyaluronic acid-based therapeutic solutions, ann…

06 October 2025

Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub

The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub in Gothenburg, Sweden. The partnership aims to leverage the combined expertise of Thermo Fisher and AstraZeneca to dri…

06 October 2025

Emagene Life Partners with IFM to Advance Global Functional Medicine

Emagene Life, Asia's leader in functional medicine and longevity, is proud to announce its official international partnership with the Institute for Functional Medicine (IFM), the leading voice for functional medicine for more than 30 years. This landmark collaboration aligns Emagene Life with the confident and compet…

03 October 2025

Gene Solutions-AMPATH Collaboration Brings Next-Gen Sequencing to India

Gene Solutions, a leading genetic testing innovator in Asia, has partnered with AMPATH (American Institute of Pathology and Laboratory Sciences), a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad. This collaboration aims to bring high-value, next-g…

30 September 2025

Gilead and Health Hope Pharma Sign Global Agreement for Encequidar

Health Hope Pharma Limited announced that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gilead") for encequidar, a first-in-class P-glycoprotein ("P-gp") inhibitor in the field of virology. HHP is currently exploring the potential of using encequidar to develop oral d…

30 September 2025

DuPont Expands Asia Pacific RO Footprint with Sinochem Memtech Deal

DuPont has signed an agreement to acquire Sinochem (Ningbo) RO Memtech Co., Ltd. to expand its reverse osmosis (RO) manufacturing footprint into China and the Asia Pacific region. With advanced membrane and fabrication production technologies, the acquisition increases DuPont's capacity to meet the growing demand in t…

26 September 2025

Cayman Chemical and Akadeum Partner to Expand Cell Isolation Technology

Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced a distribution partnership to expand access to Akadeum's next-generation cell isolation technology for cell and gene therapy development. Under the agreement, …

26 September 2025

Lonza’s Synaffix Partners with Qurient on Dual-Payload ADC Development

Synaffix B.V., a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with potential best-in-class therapeutic index, today jointly announced that it has entered into a licensing agreement with Qurient Co., Ltd., a clinical-stage biophar…

Page 26 of 36